SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001410578-22-001931
Filing Date
2022-07-07
Accepted
2022-07-06 17:34:12
Documents
105
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A kprx-20211231x10ka.htm   iXBRL 10-K/A 4610035
2 EX-23.1 kprx-20211231xex23d1.htm EX-23.1 4585
3 EX-31.1 kprx-20211231xex31d1.htm EX-31.1 8724
4 EX-32.1 kprx-20211231xex32d1.htm EX-32.1 6170
5 GRAPHIC kprx-20211231x10ka009.jpg GRAPHIC 19036
6 GRAPHIC kprx-20211231x10ka004.jpg GRAPHIC 21279
7 GRAPHIC kprx-20211231x10ka010.jpg GRAPHIC 29024
8 GRAPHIC kprx-20211231x10ka008.jpg GRAPHIC 19109
9 GRAPHIC kprx-20211231x10ka003.jpg GRAPHIC 39859
10 GRAPHIC kprx-20211231x10ka002.jpg GRAPHIC 45115
11 GRAPHIC kprx-20211231x10ka011.jpg GRAPHIC 29118
12 GRAPHIC kprx-20211231x10ka006.jpg GRAPHIC 7843
13 GRAPHIC kprx-20211231x10ka005.jpg GRAPHIC 9586
14 GRAPHIC kprx-20211231x10ka007.jpg GRAPHIC 14499
15 GRAPHIC kprx-20211231x10ka001.jpg GRAPHIC 39027
  Complete submission text file 0001410578-22-001931.txt   20067087

Data Files

Seq Description Document Type Size
16 EX-101.SCH kprx-20211231.xsd EX-101.SCH 75331
17 EX-101.CAL kprx-20211231_cal.xml EX-101.CAL 72576
18 EX-101.DEF kprx-20211231_def.xml EX-101.DEF 397228
19 EX-101.LAB kprx-20211231_lab.xml EX-101.LAB 643430
20 EX-101.PRE kprx-20211231_pre.xml EX-101.PRE 644150
99 EXTRACTED XBRL INSTANCE DOCUMENT kprx-20211231x10ka_htm.xml XML 5045819
Mailing Address 1371 EAST 2100 SOUTH SUITE 200 SALT LAKE CITY UT 84105
Business Address 1371 EAST 2100 SOUTH SUITE 200 SALT LAKE CITY UT 84105 (781) 788-8869
KIORA PHARMACEUTICALS INC (Filer) CIK: 0001372514 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-36672 | Film No.: 221069851
SIC: 2834 Pharmaceutical Preparations